Description
| Product Name | Format | CAT.No | Size |
| Uric Acid Uricase PAP | Lyo | BXC0601A | R1: 1 x 105ml R2: 5 x 20ml R4: 1 x 5ml |
| Uric Acid Uricase PAP | Lyo | BXC0601B | R1: 2 x 105ml R2: 10 x 20ml R4: 1 x 5ml |
| Uric Acid | LS | BXC0602A | R1: 4 x 50ml R2: 1 x 50ml R4: 1 x 5ml |
| Uric Acid | LS | BXC0602B | R1: 4 x 20ml R2: 1 x 20ml R4: 1 x 5ml |
| Uric Acid | Mono | BXC0603A | R1: 5 x 20ml R4: 1 x 5ml |
| Uric Acid | Mono | BXC0603B | R1: 1 x 100ml R4: 1 x 5ml |
| Uric Acid | Mono | BXC0603C | R1: 5 x 100ml R4: 1 x 5ml |
Product Description
The Biorex Diagnostics Assay is an in vitro diagnostic test for the quantitative determination of this key metabolite in human serum, plasma, and urine. As the end product of purine metabolism, its measurement provides critical insight into renal function, metabolic health, and purine-related disorders. Accurate assessment supports diagnosis and monitoring of conditions such as gout, kidney dysfunction, and metabolic imbalances.
The assay offers precise quantification to detect elevated or decreased levels, helping clinicians evaluate treatment effectiveness, dietary management, and early signs of metabolic or renal complications. Elevated results may indicate gout, urate nephropathy, or cardiovascular risk, while low readings can signal renal tubular defects, rare metabolic conditions, or nutritional deficiencies. Measurement across serum, plasma, and urine provides a complete picture of metabolic and renal status.
Key Features
• Quantitative measurement in serum, plasma, and urine for comprehensive metabolic and renal assessment
• Clinically relevant for monitoring gout, kidney disease, hyperuricaemia, hypouricaemia, and related metabolic disorders
• Ready-to-use reagents streamline workflow and ensure consistent performance
• Compatible with automated analysers and manual laboratory procedures
• High sensitivity and reproducibility across multiple platforms
Benefits
The Biorex assay delivers reliable, reproducible, and clinically meaningful data for patient monitoring, disease management, and research. Its streamlined workflow reduces technical errors and supports routine laboratory testing as well as specialised metabolic and nephrology evaluations. By enabling accurate measurement of this vital biomarker, it helps clinicians detect early signs of metabolic or renal dysfunction, monitor treatment progress, and make informed decisions that improve patient outcomes.
Contact Us for more information.
